Market Cap (In CNY)
4.02 Billion
Revenue (In CNY)
1.36 Billion
Net Income (In CNY)
279.77 Million
Avg. Volume
5.07 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.93-11.17
- PE
- 15.88
- EPS
- 0.5
- Beta Value
- 0.216
- ISIN
- CNE100002RR9
- CUSIP
- -
- CIK
- -
- Shares
- 507154000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Gang Zhu
- Employee Count
- -
- Website
- https://www.bio-gp.com.cn
- Ipo Date
- 2017-07-17
- Details
- Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic products in China and internationally. The company provides diagnostic reagents and analyzers; calibrators; reagent raw materials, such as monoclonal and polyclonal antibodies, antigen, antiserum, and microsphere; and cardiac marker, inflammation, renal function, coagulation, thyroid function, fertility, diabetes care, and thrombus products. It also offers products in the area of cardiovascular, inflammatory, diabetes, fertility, renal, liver, and others. The company was founded in 2002 and is headquartered in Nanjing, China.
More Stocks
-
SYRMA
-
FRS
-
DIADiaSorin S.p.A.
DIA
-
STARHFLSTAR HOUSING FINANCE LIMITED
STARHFL
-
BCEFFBCE Inc.
BCEFF
-
BBAR
-
DISDistil Plc
DIS
-
TSQ